Skip to content

Pharmacy

Aurobindo gets approval for Exelon generic

Aurobindo gets approval for Exelon generic

Aurobindo Pharma Ltd. has received final approval from the Food and Drug Administration for rivastigmine tartrate capsules, a dementia medication, in dosages of 1.5 mg, 3 mg, 4.5 mg and 6 mg. Aurobindo said Monday that its rivastigmine tartrate product (1.5 mg, 3 mg, 4.5 mg and 6 mg) is a generic

Prescription drug costs keep rising

Prescription drug costs keep rising

Inflation in medication costs eased last year due to spending controls and fewer new blockbusters, although there are still numerous cases of sticker shock. Spending on prescription drugs rose 5.

Cardinal, APhA honor pharmacy schools for efforts against Rx abuse

Cardinal, APhA honor pharmacy schools for efforts against Rx abuse

Student pharmacists from across the country and a clinical professor of pharmacy were honored by the Cardinal Health Foundation, Ohio State University College of Pharmacy and American Pharmacists Association (APhA) for their efforts in preventing prescription medication abuse and misuse.

Jean Coutu launches Rx image transmission service

Jean Coutu launches Rx image transmission service

Jean Coutu Group has introduced an image transmission service for new prescriptions that’s designed to make it easier for patients to fill medications. The Canadian drug chain said Wednesday that the new service is accessed via the Jean Coutu mobile application.

Mylan releases generic version of Ultram

Mylan releases generic version of Ultram

Mylan N.V. has rolled out tramadol hydrochloride extended-release tablets, a chronic pain medication, in the United States. The drug maker said its product comes in dosages of 100 mg, 200 mg and 300 mg and is a generic version of Ultram ER tablets from Valeant Pharmaceuticals International.

Novo Nordisk breaks ground on diabetes medicine facility

Novo Nordisk breaks ground on diabetes medicine facility

Novo Nordisk Inc. has broken ground on a new $1.8 billion diabetes medicine production facility in Clayton, N.C. The 833,000-square-f00t Clayton facility will make active pharmaceutical ingredients (API) for a range of Novo Nordisk’s current and future GLP-1 and insulin medicines.

Glenmark cleared to market Evista generic

Glenmark cleared to market Evista generic

Glenmark Pharmaceuticals Inc. USA has received final approval from the Food & Drug Administration for raloxifene hydrochloride tablet. Glenmark said Wednesday that its raloxifene product is a generic equivalent of Evista tablets (60 mg) from Eli Lilly and Co.

Innovation collaborates on pharmacy operations paper

Innovation collaborates on pharmacy operations paper

The Advanced Systems Division of pharmacy automation provider Innovation partnered with the Binghamton University Watson Institute for Systems Excellence (BU WISE) on a thesis paper published in the journal Expert Systems With Applications (ESWA).